Cargando…

Comparative analysis of cisplatin-induced nephrotoxicity in head and neck cancer and carcinoma cervix during concurrent chemoradiotherapy

BACKGROUND: Cisplatin is widely used as radio sensitizer in head and neck cancer (HNC) and carcinoma cervix (CaCx). This study aims to see comparative nephrotoxicity of cisplatin in HNC and in CaCx without obstructive uropathy treated by concurrent chemoradiotherapy (CCRT). MATERIALS AND METHODS: Fi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bagri, Puneet Kumar, Kapoor, Akhil, Kalwar, Ashok, Singhal, Mukesh Kumar, Singh, Daleep, Narayan, Satya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	TREATMENT TOXICITY
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236700/ https://www.ncbi.nlm.nih.gov/pubmed/25422808 http://dx.doi.org/10.4103/2278-330X.142979

Ejemplares similares

Addition of magnetic resonance imaging to computed tomography-based three-dimensional conformal radiotherapy planning for postoperative treatment of astrocytomas: Changes in tumor volume and isocenter shift
por: Bagri, Puneet Kumar, et al.
Publicado: (2015)

Analysis of Patterns of Palliative Radiotherapy in North West India: A Regional Cancer Center Experience
por: Kapoor, Akhil, et al.
Publicado: (2015)

Radiotherapy-enhanced ototoxicity in elderly
por: Malgonde, Monika S., et al.
Publicado: (2014)

Analysis of Sociodemographic Parameters of Patients Admitted in a Newly Established Palliative Care Center in a Regional Cancer Institute of North-West India
por: Singhal, Mukesh Kumar, et al.
Publicado: (2014)

Cancer related fatigue: A ubiquitous problem yet so under reported, under recognized and under treated
por: Kapoor, Akhil, et al.
Publicado: (2015)

Comparison of Single Versus Multiple Fractions for Palliative Treatment of Painful Bone Metastasis: First Study from North West India
por: Kapoor, Akhil, et al.
Publicado: (2015)

Allele Frequency of ABO Blood Group Antigen and the Risk of Esophageal Cancer
por: Kumar, Narender, et al.
Publicado: (2014)

Diagnosis of Post-Radiotherapy Local Failures in Nasopharyngeal Carcinoma: A Prospective Institutional Study
por: Bagri, Puneet Kumar, et al.
Publicado: (2014)

Multi-institutional report on toxicities of concurrent nivolumab and radiation therapy
por: Amin, Neha P., et al.
Publicado: (2018)

Analysis of outcomes and prognostic factors of acute lymphoblastic leukemia patients treated by MCP841 protocol: A regional cancer center experience
por: Kapoor, Akhil, et al.
Publicado: (2016)

Metronomic therapy with oral 6-mercaptopurine in elderly acute myeloid leukemia: A prospective pilot study
por: Kapoor, Akhil, et al.
Publicado: (2016)

High-throughput imaging-based nephrotoxicity prediction for xenobiotics with diverse chemical structures
por: Su, Ran, et al.
Publicado: (2015)

Zoledronate dysregulates fatty acid metabolism in renal tubular epithelial cells to induce nephrotoxicity
por: Cheng, Lili, et al.
Publicado: (2017)

Mediastinal schwannoma: A clinical, pathologic, and imaging review
por: Kapoor, Akhil, et al.
Publicado: (2015)

A case of CD68 negative histiocytic sarcoma of axilla masquerading as metastatic breast cancer
por: Nangal, Jitendra Kumar, et al.
Publicado: (2014)

Double Primary Malignancies: A Clinical & Pathological Analysis Report from a Regional Cancer Institute in India
por: Bagri, Puneet Kumar, et al.
Publicado: (2014)

Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
por: Zhou, Xi-Lei, et al.
Publicado: (2021)

Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil
por: Tamaki, Yukihisa, et al.
Publicado: (2018)

Concurrent chemoradiotherapy with intravenous cisplatin and docetaxel for advanced oral cancer
por: Sato, Kotaro, et al.
Publicado: (2019)

DNA topoisomerase VIII: a novel subfamily of type IIB topoisomerases encoded by free or integrated plasmids in Archaea and Bacteria
por: Gadelle, Danièle, et al.
Publicado: (2014)

Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities
por: Xiao, Canhua, et al.
Publicado: (2018)

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data
por: Holyoake, Daniel L.P., et al.
Publicado: (2017)

Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas
por: Hoek, Jantien, et al.
Publicado: (2016)

Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin
por: Cho, Hundo, et al.
Publicado: (2022)

Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin
por: Cho, Hundo, et al.
Publicado: (2022)

RTT-led IGRT for cervix cancer; training, implementation and validation
por: Alexander, S.E., et al.
Publicado: (2019)

Mechanisms of Cisplatin Nephrotoxicity
por: Miller, Ronald P., et al.
Publicado: (2010)

Prevention of cisplatin nephrotoxicity
por: Hayati, Fatemeh, et al.
Publicado: (2015)

Cisplatin-Based Chemotherapy versus Cetuximab in Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer Treatment
por: Hu, Ming-Hung, et al.
Publicado: (2014)

Concurrent Chemoradiotherapy With Weekly Low-Dose Cisplatin for Japanese Patients With Head and Neck Squamous Cell Carcinoma
por: Shinohara, Shogo, et al.
Publicado: (2021)

Hematological Toxicities of Concurrent Chemoradiotherapies in Head and Neck Cancers: Comparison Among Cisplatin, Nedaplatin, Lobaplatin, and Nimotuzumab
por: Wu, Qiuji, et al.
Publicado: (2021)

Concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of the cervix in a uterus didelphys with vaginal septum
por: Kaneyasu, Yuko, et al.
Publicado: (2019)

Successful Concurrent Chemoradiotherapy with Cisplatin plus Vinorelbine for Locally Advanced Thymic Carcinoma
por: Fukushima, Toshirou, et al.
Publicado: (2014)

Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma
por: Wang, Kailin, et al.
Publicado: (2019)

Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer
por: Chitapanarux, I, et al.
Publicado: (2010)

Modified Weekly Cisplatin-Based Chemotherapy Is Acceptable in Postoperative Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer
por: Lu, Hsueh-Ju, et al.
Publicado: (2015)

Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy
por: Hu, Ke, et al.
Publicado: (2018)

Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study)
por: Driessen, Chantal M., et al.
Publicado: (2019)

PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix
por: Mann, Minakshi, et al.
Publicado: (2019)

Assessing costs of a hypertension management program: An application of the HEARTS costing tool in a program planning workshop in Thailand
por: Husain, Muhammad Jami, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kt03gv1vcq0fga1g6jk0jneqie